These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 18585487)

  • 1. Recovery of normal ventricular function in patients with dilated cardiomyopathy: relevance of the etiology.
    Santangeli P; Marzo F; Macchione A; Bellocci F; Crea F; Pieroni M
    Am Heart J; 2008 Jul; 156(1):e3. PubMed ID: 18585487
    [No Abstract]   [Full Text] [Related]  

  • 2. Recovery of normal ventricular function in patients with dilated cardiomyopathy: predictors of an increasingly prevalent clinical event.
    Binkley PF; Lesinski A; Ferguson JP; Hatton PS; Yamokoski L; Hardikar S; Cooke GE; Leier CV
    Am Heart J; 2008 Jan; 155(1):69-74. PubMed ID: 18082492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. eComment: rationale for left ventricular reconstruction taking into account the swirling nature of intracardiac blood flow.
    Bockeria LA; Kiknadze GI; Gorodkov AY
    Interact Cardiovasc Thorac Surg; 2010 May; 10(5):665. PubMed ID: 20403981
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment.
    Merlo M; Pyxaras SA; Pinamonti B; Barbati G; Di Lenarda A; Sinagra G
    J Am Coll Cardiol; 2011 Mar; 57(13):1468-76. PubMed ID: 21435516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peripartum cardiomyopathy: a comprehensive review.
    Abboud J; Murad Y; Chen-Scarabelli C; Saravolatz L; Scarabelli TM
    Int J Cardiol; 2007 Jun; 118(3):295-303. PubMed ID: 17208320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery and recurrence of left ventricular systolic dysfunction in patients with idiopathic dilated cardiomyopathy.
    Moon J; Ko YG; Chung N; Ha JW; Kang SM; Choi EY; Rim SJ
    Can J Cardiol; 2009 May; 25(5):e147-50. PubMed ID: 19417864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hypertrophic cardiomyopathy: course characteristics in long-term follow-up].
    Belenkov IuN; Privalova EV; Kaplunova VIu; Fomin AA
    Ter Arkh; 2008; 80(8):18-25. PubMed ID: 18807535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of QRS prolongation and its relation to mechanical dyssynchrony in idiopathic dilated cardiomyopathy in childhood.
    Chen CA; Hsiao CH; Wang JK; Lin MT; Wu ET; Chiu SN; Chiu HH; Wu MH
    Am J Cardiol; 2009 Jan; 103(1):103-9. PubMed ID: 19101238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limited surgical approach for explanting the HeartMate II left ventricular assist device after myocardial recovery.
    Haj-Yahia S; Birks EJ; Dreyfus G; Khaghani A
    J Thorac Cardiovasc Surg; 2008 Feb; 135(2):453-4. PubMed ID: 18242292
    [No Abstract]   [Full Text] [Related]  

  • 10. Comments on the article by Abboud et al. "Peripartum cardiomyopathy: a comprehensive review": a tribute to: A.B. Benchimol and P. Schlesinger.
    Benchimol Barbosa PR
    Int J Cardiol; 2008 Jun; 127(1):142-3. PubMed ID: 17544526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and predictors of in-hospital mortality of patients with heart failure with preserved left ventricular ejection fraction.
    Pérez de Isla L; Zamorano J; Hernández N; Contreras L; Rodrigo JL; Almería C; Aubele AL; Mataix L; Macaya C
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1011-5. PubMed ID: 18799963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiomyopathy of insulin resistance.
    Witteles RM; Fowler MB
    Heart Fail Clin; 2006 Jan; 2(1):13-23. PubMed ID: 17386873
    [No Abstract]   [Full Text] [Related]  

  • 13. Ventricular remodeling fundamental to the progression (and regression) of heart failure.
    Udelson JE; Konstam MA
    J Am Coll Cardiol; 2011 Mar; 57(13):1477-9. PubMed ID: 21435517
    [No Abstract]   [Full Text] [Related]  

  • 14. Interaction between two predictors of functional outcome after revascularization in ischemic cardiomyopathy: left ventricular volume and amount of viable myocardium.
    Mandegar MH; Yousefnia MA; Roshanali F; Rayatzadeh H; Alaeddini F
    J Thorac Cardiovasc Surg; 2008 Oct; 136(4):930-6. PubMed ID: 18954632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction of myocardial blood flow reserve in idiopathic dilated cardiomyopathy without overt heart failure and its relation with functional indices: an echo-Doppler and positron emission tomography study.
    Morales MA; Neglia D; L'Abbate A
    J Cardiovasc Med (Hagerstown); 2008 Aug; 9(8):778-82. PubMed ID: 18607240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramyocardial angiogenic cell precursors in nonischemic dilated cardiomyopathy.
    Arom KV; Ruengsakulrach P; Belkin M; Tiensuwan M
    Asian Cardiovasc Thorac Ann; 2009 Aug; 17(4):382-8. PubMed ID: 19713335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medico-legal assessment of dilated cardiomyopathy].
    Molisso C; Molisso V
    G Ital Cardiol (Rome); 2007 May; 8(5):299-305. PubMed ID: 17650688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profiles and outcomes for Omani children with dilated cardiomyopathy seen in a regional referral hospital.
    Jaiyesimi O; Kasem M
    Cardiol Young; 2009 Apr; 19(2):145-51. PubMed ID: 19224668
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whither Withering's Legacy? Digoxin's role in our contemporary pharmacopeia for heart failure.
    Young JB
    J Am Coll Cardiol; 2005 Aug; 46(3):505-7. PubMed ID: 16053965
    [No Abstract]   [Full Text] [Related]  

  • 20. Referencing for reviews: How to distinguish unwillingness from mission impossible.
    Chen-Scarabelli C; Scarabelli TM
    Int J Cardiol; 2008 Jun; 127(1):144-5. PubMed ID: 18053591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.